Now that California – the world's sixth-largest economy – has a legal medical and recreational marijuana market up and running, it's the perfect time to get a finger on the pulse of that market.
It's been an exciting and profitable few weeks here…
The numbers so far are staggering – as I've been predicting they would be for months. As I mentioned earlier this month, in the days following the Jan. 1, 2018, "debut" of recreational adult use, the seven biggest pot stocks by market cap alone bulked up to the tune of $1.7 billion.
My paid-up Nova-X Report readers have seen some nice gains in our pot stock model portfolio, too.
The profits do give some idea of what's happening, but the truth is, California is such a lucrative marijuana market, and so important to the future of legal weed, that I wanted to know exactly what's been going on in the Golden State since it went "green" a few weeks ago.
I'm talking about a much more in-depth picture than you can get in the mainstream media, of course.
You won't get this anywhere else…
My Marijuana Man on the Inside
For a look at what's coming in this key state, I called one of my best contacts in the legal marijuana arena: Chris Walsh – editorial vice president at Marijuana Business Daily.
This industry newsletter not only puts out a great publication, but it also organizes some of the best conferences in the business.
I'm talking about MJBizCon, which is held in a few locations each year. I attended one last year and brought back a tremendous amount of valuable (profitable) information that I've shared with you folks over the past few months.
Walsh was the founding editor of MBD way back in 2011, when hardly anyone was talking about legalized recreational marijuana. In other words, he's basically seen it all. So I wanted to get him on the record about what he saw on Jan. 1 – the day cannabis went fully legal in California – and in the days since then.
Note: You can learn how to get access to all of Michael's California marijuana market recommendations right here. All his paid-up Nova-X Report subscribers get his favorite plays.
After all, North American legal marijuana sales totaled $6.7 billion in 2016. California – with its nearly 40 million residents – could rake in $20 billion per year in cannabis sales on its own within a few years. And by year's end, legal marijuana sales across the country could more than triple.
Here's why that's great news.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.